Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
First post-graduate course of its kind to offer working professionals in the field of cardiovascular sciences the opportunity to obtain a formal graduate qualification whilst continuing employment
Brussels/London, Thursday 24 July 2014. LSE Health and the European Heart Academy (EHA) of the European Society of Cardiology (ESC) are pleased to announce the launch of a new, executive-style MSc aimed at professionals working in the field of cardiovascular sciences.The MSc in Health Economics, Outcomes and Management in Cardiovascular Sciences aims to equip cardiovascular specialists with the health management, economics, research and policy skills required to take on advisory, management or leadership roles within the field. Designed by academics at the London School of Economics and Political Science (LSE) with support from the European Heart Academy of the ESC, based in Brussels, Belgium, it is the first post-graduate course of its kind to offer working professionals in the field of cardiovascular sciences the opportunity to obtain a formal graduate qualification whilst continuing employment. Participants will explore new advisory, management, and leadership roles within the cardiovascular field through four two-week intensive courses. In addition to gaining a theoretical and conceptual understanding of health economics, outcomes research, and management, the MSc will also help the next generation of leaders in their field to acquire the skills to accelerate their careers or refocus into related sectors, such as hospital management, the pharmaceutical and medical devices industries, consultancies, government and non-governmental organisations. Professor Elias Mossialos, Director of LSE Health, said:
“Cardiovascular diseases remain the main cause of morbidity and mortality globally and both medical and economic knowledge is essential to achieve the best results for patients, care providers and health systems. We are delighted to be partnering with the European Society of Cardiology to deliver this unique graduate programme designed for experts working in this field.”
Professor Panos Vardas, President of the ESC, said:
“This course will not only provide cardiovascular specialists with the opportunity to acquire world-class knowledge in health economics, outcomes research and management, it will allow the next generation of leaders to broaden their horizons in an international environment.”
Professor Paulus Kirchhof, of the European Heart Academy and the ESC’s academic liaison to the new programme, said:
“We are delighted that LSE has partnered with the European Heart Academy to develop an interdisciplinary graduate programme in Health Economics, Outcomes and Management. We believe that this course will be able to nurture future leaders in cardiovascular sciences. I look forward to seeing this unique partnership come to fruition.”
The LSE MSc in Health Economics, Outcomes, and Management in Cardiovascular Sciences will run from December 2015. -Ends-
Applications for LSE MSc in Health Economics, Outcomes, and Management in Cardiovascular Sciences open in October 2014 for entry in October 2015. Further information about admissions can be found at lse.ac.uk/study/graduate/home.aspxThe programme is expected to attract 30 students every year. The MSc in Health Economics, Outcomes and Management in Cardiovascular Sciences will offer six mandatory courses (Economic analysis for health policy; Quality and outcomes in cardiovascular sciences; Economic evaluation in health care; Systematic review and meta-analysis; Cardiovascular epidemiology and prevention; Dissertation in health economics, outcomes, and management) in addition to a wide variety of optional courses. LSE is a specialist university with an international intake and a global reach, and an outstanding reputation for academic excellence. Its research and teaching span the full breadth of the social sciences, from economics, politics and law to sociology and finance. LSE Health’s mission is to advance, transmit and sustain knowledge and understanding through the conduct of research, teaching and scholarship at the highest international standards, for the benefit of the international and national health policy community. Bringing together a core team of researchers and academics, LSE Health promotes and draws upon the multidisciplinary expertise of 50 staff members, 20 associated academics and a number of postgraduate students. The European Heart Academy of the ESC trains future leaders in cardiovascular medicine by fostering collaboration between top-tier academic institutions in Europe and ESC’s cardiologists and hereto runs specialised courses for aspiring candidates to acquire academic degrees. The European Society of Cardiology (ESC) represents more than 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
© 2017 European Society of Cardiology. All rights reserved